Literature DB >> 34937272

Economical and financial constraints for ophthalmologists during COVID-19 pandemic.

Bharat Gurnani1, Kirandeep Kaur2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 34937272      PMCID: PMC8917551          DOI: 10.4103/ijo.IJO_2173_21

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
  5 in total

1.  Comments on: Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study.

Authors:  Bharat Gurnani; Kirandeep Kaur
Journal:  Indian J Ophthalmol       Date:  2021-01       Impact factor: 1.848

2.  The financial and employment effects of coronavirus disease 2019 on physicians in the United States.

Authors:  Bhagwan Satiani; Carolyn A Davis
Journal:  J Vasc Surg       Date:  2020-09-01       Impact factor: 4.268

3.  The impacts of corporatisation of healthcare on medical practice and professionals in Maharashtra, India.

Authors:  Shweta Marathe; Benjamin M Hunter; Indira Chakravarthi; Abhay Shukla; Susan F Murray
Journal:  BMJ Glob Health       Date:  2020-02-11

4.  Comments on: COVID-19 pandemic - Testing times for postgraduate medical education.

Authors:  Bharat Gurnani; Kirandeep Kaur
Journal:  Indian J Ophthalmol       Date:  2021-07       Impact factor: 1.848

5.  Impact of COVID-19 pandemic on income and opportunities of ophthalmologists in India: Ophthalmologists' Workplace Expectations and Satisfaction Survey (OWESS) Report 1.

Authors:  Sreeni Edakhlon; Prashob Mohan; Gopal S Pillai; Lalit Verma; Santosh G Honavar; Namrata Sharma; Ambily Nadaraj
Journal:  Indian J Ophthalmol       Date:  2021-08       Impact factor: 1.848

  5 in total
  1 in total

1.  Commentary: Can we depend on the point-of-care rapid antigen testing for SARS-CoV-2 for routine ophthalmic procedures and high volume ophthalmic settings?

Authors:  Deepak Mishra; Kirandeep Kaur; Bharat Gurnani
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.